| Name | Title | Contact Details |
|---|
Patient Care Solutions is a Burlington, ON-based company in the Business Services sector.
Ralph Lauren Corporation is a global leader in the design, marketing, and distribution of luxury lifestyle products. Founded in 1967, the company has established itself as a prominent American lifestyle brand, recognized for its iconic designs and contributions to fashion. Ralph Lauren offers a diverse range of products, including apparel for men, women, and children, as well as footwear, accessories, home furnishings, fragrances, and luxury hospitality ventures. The brand portfolio features well-known lines such as Ralph Lauren, Polo Ralph Lauren, and Lauren Ralph Lauren, among others. The company employs a multichannel distribution strategy, utilizing retail stores, online platforms, and licensing partnerships to reach a global audience. Ralph Lauren is celebrated for its ability to capture the essence of the American spirit, influencing fashion and lifestyle branding worldwide.
DPA Components Intl is a Simi Valley, CA-based company in the Business Services sector.
The Sefton Group is a Grand Rapids, MI-based company in the Business Services sector.
We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)